Avicanna Inc.

TSX:AVCN Stock Report

Market Cap: CA$25.1m

Avicanna Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Avicanna.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth54.4%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Take Care Before Jumping Onto Avicanna Inc. (TSE:AVCN) Even Though It's 31% Cheaper

Nov 17
Take Care Before Jumping Onto Avicanna Inc. (TSE:AVCN) Even Though It's 31% Cheaper

Why Investors Shouldn't Be Surprised By Avicanna Inc.'s (TSE:AVCN) 35% Share Price Surge

Aug 28
Why Investors Shouldn't Be Surprised By Avicanna Inc.'s (TSE:AVCN) 35% Share Price Surge

Market Participants Recognise Avicanna Inc.'s (TSE:AVCN) Revenues Pushing Shares 79% Higher

Jul 11
Market Participants Recognise Avicanna Inc.'s (TSE:AVCN) Revenues Pushing Shares 79% Higher

It's Down 35% But Avicanna Inc. (TSE:AVCN) Could Be Riskier Than It Looks

May 24
It's Down 35% But Avicanna Inc. (TSE:AVCN) Could Be Riskier Than It Looks

Shareholders Should Be Pleased With Avicanna Inc.'s (TSE:AVCN) Price

Apr 05
Shareholders Should Be Pleased With Avicanna Inc.'s (TSE:AVCN) Price

Here's Why Avicanna (TSE:AVCN) Can Afford Some Debt

Apr 18
Here's Why Avicanna (TSE:AVCN) Can Afford Some Debt

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Avicanna has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

TSX:AVCN - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202425-7-3-3N/A
6/30/202425-7-10N/A
3/31/202422-701N/A
12/31/202317-9-2-1N/A
9/30/202312-12-2-1N/A
6/30/20236-14-7-7N/A
3/31/20234-16-6-6N/A
12/31/20224-15-8-7N/A
9/30/20224-16-11-11N/A
6/30/20224-16-9-9N/A
3/31/20224-15-12-11N/A
12/31/20213-17-12-12N/A
9/30/20212-24-12-11N/A
6/30/20212-29-13-12N/A
3/31/20212-34-17-16N/A
12/31/20202-33-16-14N/A
9/30/20202-25-18-13N/A
6/30/20201-24-24-16N/A
3/31/20200-21-26-17N/A
12/31/20190-22-27-18N/A
9/30/20190-18-21-16N/A
6/30/20190-14-15-12N/A
3/31/20190-11-7-6N/A
12/31/20180-7-9-5N/A
9/30/20180-5-10-6N/A
12/31/20170-3N/A-2N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if AVCN's forecast earnings growth is above the savings rate (2.3%).

Earnings vs Market: Insufficient data to determine if AVCN's earnings are forecast to grow faster than the Canadian market

High Growth Earnings: Insufficient data to determine if AVCN's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if AVCN's revenue is forecast to grow faster than the Canadian market.

High Growth Revenue: Insufficient data to determine if AVCN's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if AVCN's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y